feed,title,long_url,short_url
SeekingAlpha,Palatin's PL9643 ophthalmic solution misses primary endpoint in mid-stage dry eye disease study,https://seekingalpha.com/news/3644384,
SeekingAlpha,CSI Board authorizes $10M addition to buyback program,https://seekingalpha.com/news/3644385,
